These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3464084)

  • 1. The antifibrinolytic properties of cimetidine.
    Helgstrand U
    Scand J Gastroenterol Suppl; 1986; 121():40-5. PubMed ID: 3464084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine--an antifibrinolytic agent?
    Helgstrand U
    Scand J Gastroenterol; 1983 Mar; 18(2):317-9. PubMed ID: 6673059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cimetidine on gastric mucosal cell proliferation in man.
    Svendsen LB; Hansen OH; Larsen JK; Pedersen T; Johansen A
    Scand J Gastroenterol; 1986 Dec; 21(10):1271-4. PubMed ID: 3810001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis and peptic ulcer.
    Helgstrand U
    Acta Chir Scand Suppl; 1988; 547():39-41. PubMed ID: 3227745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cimetidine on human gastric and duodenal prostanoid synthesis.
    Branski D; Sharon P; Karmeli F; Rachmilewitz D
    Scand J Gastroenterol; 1984 Jun; 19(4):457-60. PubMed ID: 6589742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cimetidine on the amounts of histamine in the gastric mucosa of patients with gastric or duodenal ulcers.
    Man WK; Saunders JH; Ingoldby C; Spencer J
    Gut; 1981 Nov; 22(11):923-6. PubMed ID: 7308846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term effects of H2-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa.
    Ribet A; Balas D; Bastie MJ; Senegas-Balas F; Escourrou J; Bommelaer G; Pradayrol L
    Scand J Gastroenterol Suppl; 1981; 70():155-74. PubMed ID: 6118944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum.
    Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A
    Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers.
    Festen HP; Lamers CB; Tangerman A; van Tongeren JH
    Postgrad Med J; 1980 Oct; 56(660):698-701. PubMed ID: 7220403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.
    Wodziński MA; Bardhan KD; Reilly JT; Cooper P; Preston FE
    Gut; 1993 Oct; 34(10):1310-4. PubMed ID: 8244093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
    Vetvik K; Schrumpf E; Mowinckel P; Aase S; Andersen KJ
    Scand J Gastroenterol; 1994 Nov; 29(11):995-1000. PubMed ID: 7871380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemistry of the gastric and duodenal mucosa under cimetidine and carbenoxolone treatment.
    Lojda Z; Maratka Z
    Scand J Gastroenterol Suppl; 1989; 167():13-5. PubMed ID: 2617161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ranitidine on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients.
    Vetvik K; Schrumpf E; Andersen KJ; Skagen DW; Halvorsen OJ
    Scand J Gastroenterol; 1990 Nov; 25(11):1123-8. PubMed ID: 2274735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
    Jönsson KA; Bodemar G; Norrby K; Walan A; Tysk C
    Scand J Gastroenterol; 1988 Mar; 23(2):199-208. PubMed ID: 3283917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of indomethacin induced gastroduodenal mucosal injury and gastrointestinal symptoms with cimetidine in normal subjects.
    Frank WO; Wallin BA; Berkowitz JM; Kimmey MB; Palmer RH; Rockhold F; Young MD
    J Rheumatol; 1989 Sep; 16(9):1249-52. PubMed ID: 2810283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cimetidine on the regeneration of the gastric mucosa around a peptic ulcer.
    Kasajima M; Kanayama R; Konishi F
    Am J Gastroenterol; 1982 May; 77(5):331-4. PubMed ID: 7081191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer.
    Herszènyi L; Plebani M; Carraro P; De Paoli M; Cardin R; Di Mario F; Kusstatscher S; Naccarato R; Farinati F
    Am J Gastroenterol; 1997 May; 92(5):843-7. PubMed ID: 9149198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?].
    De Lazzari F; Venturi C; Fregona I; Galliani EA; Bortolami M; Violato D; Floreani AR; Plebani M; Naccarato R
    Minerva Gastroenterol Dietol; 1994 Mar; 40(1):1-9. PubMed ID: 8204699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced gastric and duodenal platelet-activating factor and leukotriene generation in duodenal ulcer patients.
    Ackerman Z; Karmeli F; Ligumsky M; Rachmilewitz D
    Scand J Gastroenterol; 1990 Sep; 25(9):925-34. PubMed ID: 2171135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.